{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:07:51Z","timestamp":1770822471170,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bpobgyn.2011.11.003","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T12:38:22Z","timestamp":1323520702000},"page":"209-220","source":"Crossref","is-referenced-by-count":10,"title":["Human papillomavirus deoxyribonucleic acid testing in developed countries"],"prefix":"10.1016","volume":"26","author":[{"given":"Neerja","family":"Bhatla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.11.003_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib4","unstructured":"Approval letter: Digene Hybrid Capture 2 High-Risk HPV DNA Test\u2013P890064\/S009. Rockville, MD: Center for Devices and Radiological Health, U.S. Food and Drug Administration, 2003; http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/p890064s009a.pdf [last accessed 15.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib5","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/JCM.36.11.3248-3254.1998","article-title":"Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies","volume":"36","author":"Peyton","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib6","unstructured":"Approval letter: Cervista HPV High-Risk and Genfind DNA Extraction Kit\u2013P080014. Rockville, MD: Center for Devices and Radiological Health, U.S. Food and Drug Administration, 2009; http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf8\/P080014A.pdf [last accessed 15.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib7","unstructured":"Approval letter: Cervista HPV 16\/18\u2013P080015. Rockville, MD: Center for Devices and Radiological Health, U.S. Food and Drug Administration, 2009; http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf8\/P080015A.pdf [last accessed 15.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib8","first-page":"147","article-title":"Retrospective and prospective evaluation of the Amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples","volume":"14","author":"Poljak","year":"2005","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib9","unstructured":"Approval letter: Cobas HPV Test\u2013P100020. Rockville, MD: Center for Devices and Radiological Health, U.S. Food and Drug Administration, 2011; http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/p100020a.pdf [last accessed 15.11.11]."},{"issue":"Suppl. 10","key":"10.1016\/j.bpobgyn.2011.11.003_bib10","doi-asserted-by":"crossref","first-page":"K42","DOI":"10.1016\/j.vaccine.2008.05.002","article-title":"New technologies in cervical cancer screening","volume":"26","author":"Gravitt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/14737159.8.4.405","article-title":"Human papillomavirus E6\/E7 mRNA testing as a predictive marker for cervical carcinoma","volume":"8","author":"Lie","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib12","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2011.11.003_bib13","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1386-6532(09)70003-4","article-title":"Principles and analytical performance of Abbott Real Time HR HPV test","volume":"45","author":"Huang","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.293.6548.659","article-title":"Screening for squamous cervical cancer: the duration of low risk after negative result of cervical cytology and its implication for screening policies","volume":"293","author":"IARC Working Group on Evaluation of Cervical Cancer Screening Programmes","year":"1986","journal-title":"BMJ"},{"issue":"8544","key":"10.1016\/j.bpobgyn.2011.11.003_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(87)92695-X","article-title":"Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes","volume":"1","author":"Laara","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib16","first-page":"403","article-title":"A screening programme for cervical cancer that worked","volume":"17","author":"Hakama","year":"1988","journal-title":"Cancer Surv"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjc.1996.196","article-title":"Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer","volume":"73","author":"Sasieni","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib18","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26S","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib19","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1024806707399","article-title":"Comparison of HPV-based assays with Papanicoloau smears for cervical cancer screening in Morelos State, Mexico","volume":"14","author":"Salmeron","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/jnci\/92.10.818","article-title":"Human papillomavirus DNA testing for cervical cancer screening in low-resource settings","volume":"92","author":"Kuhn","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/oxfordjournals.jncimonographs.a003488","article-title":"Primary screening of cervical cancer with human papillomavirus tests","volume":"31","author":"Franco","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"ACOG Practice Bulletin No. 109: Cervical Cytology Screening","volume":"114","author":"American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib26","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib27","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/cncr.10927","article-title":"Absolute risk of a subsequent abnormal Pap among oncogenic human papillomavirus DNA-positive cytologically negative women","volume":"95","author":"Castle","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z","article-title":"PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytologically normal cervical smears","volume":"68","author":"Rozendal","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib31","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ijc.25974","article-title":"Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy","volume":"129","author":"Gravitt","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/path.1480","article-title":"The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix","volume":"201","author":"Zielinski","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1097-0142(20010225)93:1<8::AID-CNCR9001>3.0.CO;2-K","article-title":"Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases","volume":"93","author":"Krane","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.283.1.81","article-title":"HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer","volume":"283","author":"Wright","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2007.01.023","article-title":"Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis","volume":"105","author":"Petignat","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ypmed.2011.03.018","article-title":"Comparative community outreach to increase cervical cancer screening in the Mississippi Delta","volume":"52","author":"Castle","year":"2011","journal-title":"Prev Med"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arcmed.2009.06.003","article-title":"The expected impact of HPV vaccination on the accuracy of cervical cancer screening: The need for a paradigm change","volume":"40","author":"Franco","year":"2009","journal-title":"Arch Med Res"},{"issue":"Suppl. 3","key":"10.1016\/j.bpobgyn.2011.11.003_bib39","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib40","first-page":"203","article-title":"ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants","volume":"124","author":"Schiffman","year":"2000","journal-title":"Acta Cytol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jnci\/92.5.397","article-title":"Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomised trial","volume":"92","author":"The Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.38698.458866.7C","article-title":"Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies","volume":"332","author":"Legood","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnci\/94.2.102","article-title":"Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)","volume":"94","author":"Sherman","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cct.2006.04.001","article-title":"Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design","volume":"27","author":"Cotton","year":"2006","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.bjc.6603822","article-title":"TOMBOLA Group Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women","volume":"97","author":"Cotton","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib48","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib49","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib50","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib51","first-page":"27","article-title":"The significance of HPV in the follow-up period after treatment for CIN","volume":"31","author":"Gallwas","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.25731","article-title":"A comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat","volume":"129","author":"Taylor","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1258\/jms.2010.010019","article-title":"Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis","volume":"17","author":"Accetta","year":"2010","journal-title":"J Med Screen"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/dji162","article-title":"Cost-effectiveness of HPV DNA testing in the UK, the Netherlands, France, Italy","volume":"97","author":"Kim","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/AJCPRI8XPQUEAA3K","article-title":"Special commentary: patient safety and the next generation of HPV DNA tests","volume":"134","author":"Kinney","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/08870449508401948","article-title":"Psychological consequences of positive results in cervical cancer screening","volume":"10","author":"Wardle","year":"1995","journal-title":"Psychol Health"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/pmed.1995.1096","article-title":"Psychological response to cervical screening","volume":"24","author":"Bell","year":"1995","journal-title":"Prev Med"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.2044-8287.1996.tb00501.x","article-title":"Reducing anxiety in women referred for colposcopy using an information booklet","volume":"1","author":"Marteau","year":"1996","journal-title":"Br J Health Psychol"},{"key":"10.1016\/j.bpobgyn.2011.11.003_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.bjc.6602312","article-title":"Making sense of information about HPV in cervical screening: a qualitative study","volume":"92","author":"Waller","year":"2005","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.bpobgyn.2011.11.003_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"ARTISTIC Trial Study Group. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2011.11.003_bib61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1438.2007.01113.x","article-title":"The psychosocial impact of human papillomavirus testing in primary cervical screening \u2013 a study within a randomized trial","volume":"18","author":"Kitchener","year":"2008","journal-title":"Int J Gynecol Cancer"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T15:58:18Z","timestamp":1593359898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693411001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1521693411001659"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.11.003","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}